Message

AIRS will lead to the future of orthopedic surgery.
We prepare for the next era of surgical platforms,
SURGERY 4.0.

Hello This is Sanghyun Joung, the CEO of the Corporation.
When I first learnt about robotic surgery in 2002, it appeared like a technology from the distant future.
However, with the number of robots that are already assisting medical staff in the operating room. Being at the forefront of surgical robot research/development for the past 20 years, I have experienced that good research results were not being used in clinical fields and disappeared.
At the Medical Device Clinical Trial Center of Kyungpook National University Hospital, I had researched and conducted medical device licensing, clinical trials, and insurance registration. At the Medical Device Clinical Trial Center of Kyungpook National University Hospital,
I had researched and conducted medical device licensing, clinical trials, and insurance registrations.
Based on everything I've learnt thus far; I established a company that specializes in developing surgical robots in 2020. We developed a robot system that assists in fracture surgery as the first commercialized product,
and now we are developing a bone endoscopic robot system as a follow-up product that can treat the inside of the bone with minimal invasiveness. We are always grateful to the medical staff who provide ideas and feedback on the research results, and to the professors and researchers who solve technical difficulties together. We hope you enjoy following our journey to becoming a world leader in developing surgical robot systems.